ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 32 filers reported holding ASLAN PHARMACEUTICALS LTD in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $170,000 | -22.4% | 343,720 | +41.0% | 0.05% | -19.3% |
| Q1 2022 | $219,000 | -73.3% | 243,720 | -66.7% | 0.06% | -72.3% |
| Q4 2021 | $820,000 | -37.1% | 732,500 | 0.0% | 0.21% | -40.5% |
| Q3 2021 | $1,304,000 | -41.7% | 732,500 | +8.1% | 0.35% | -26.1% |
| Q2 2021 | $2,236,000 | -1.5% | 677,500 | 0.0% | 0.47% | -13.2% |
| Q1 2021 | $2,270,000 | +1284.1% | 677,500 | +687.0% | 0.54% | +917.0% |
| Q3 2020 | $164,000 | -4.7% | 86,082 | 0.0% | 0.05% | +6.0% |
| Q2 2020 | $172,000 | +95.5% | 86,082 | 0.0% | 0.05% | +35.1% |
| Q1 2020 | $88,000 | -63.2% | 86,082 | -26.9% | 0.04% | -54.9% |
| Q4 2019 | $239,000 | – | 117,682 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 1,270,758 | $2,262,000 | 0.72% |
| MANGROVE PARTNERS IM, LLC | 2,514,576 | $4,476,000 | 0.40% |
| TANG CAPITAL MANAGEMENT LLC | 975,305 | $1,736,000 | 0.36% |
| DAFNA Capital Management LLC | 732,500 | $1,304,000 | 0.35% |
| KNOTT DAVID M | 478,186 | $851,000 | 0.31% |
| Vivo Capital, LLC | 2,840,909 | $5,057,000 | 0.23% |
| SABBY MANAGEMENT, LLC | 688,400 | $1,225,000 | 0.17% |
| MYDA Advisors LLC | 236,165 | $420,000 | 0.12% |
| Affinity Asset Advisors, LLC | 250,000 | $445,000 | 0.11% |
| RTW INVESTMENTS, LP | 3,250,000 | $5,785,000 | 0.09% |